Tag Archives: comparative effectiveness research

GAO Announces Members of the Methodology Committee of the Patient-Centered Outcomes Research Institute

Today, Gene Dodaro, Comptroller General of the United States and head of the U.S. Government Accountability Office (GAO), announced the appointment of the following 15 individuals to the Methodology Committee of the Patient-Centered Outcomes Research Institute (PCORI).

The Traveling Advocate Flies . . .and Flies . . . and Flies

“Thank you for what you said.” “Thanks for your comments.” Words heard over and over in elevators, hallways, and coffee breaks in the last couple of weeks, as Colorectal Cancer Coalition research advocates spoke out during research-focused meetings … appreciation expressed for the reality-based voices of patients as research gets planned and evaluated. We’ve been busy with three different meetings in the last ten days . . . and a big one coming up.

Colorectal Cancer News in Brief: July 10

Research this week finds FDG/PET able to predict response to chemotherapy even after one treatment, and chemotherapy before surgery for liver mets makes CT scan evaluation less accurate. Finding the best imaging methods to diagnosis and monitor cancer and comparing new colorectal cancer screening technologies to current standards are among recommended priorities for comparative effectiveness research (CER).  The FDA reports new egg safety rules and the recall of a powdered dietary supplement. Videos of cancer patients are now online discussing the emotional impact of their diagnosis in The Day I Found Out.